These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2156301)

  • 21. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepine-receptor ligands and hepatic encephalopathy: a causal relationship?
    Rothstein JD
    Hepatology; 1994 Jan; 19(1):248-50. PubMed ID: 8276362
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of flumazenil in hepatic encephalopathy.
    Grimm G; Katzenschlager R; Holzner F; Ferenci P; Schneeweiss B; Laggner A; Lenz K; Druml W; Madl C
    Eur J Anaesthesiol Suppl; 1988; 2():147-9. PubMed ID: 2842131
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist].
    Janicki P; Rewerski W
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic encephalopathy: a neurochemical disorder.
    Jones EA; Schafer DF
    Prog Liver Dis; 1986; 8():525-40. PubMed ID: 2872697
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
    Basile AS; Gammal SH; Mullen KD; Jones EA; Skolnick P
    J Neurosci; 1988 Jul; 8(7):2414-21. PubMed ID: 2854841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.
    Jones EA; Basile AS; Skolnick P
    Adv Exp Med Biol; 1990; 272():121-34. PubMed ID: 1966504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The quantitative electroencephalogram in a case of acute hepatic encephalopathy treated with flumazenil].
    Frenkel AL; Hermant JL; Blaise M; Volter F; Pourriat JL
    Cah Anesthesiol; 1991; 39(1):61-2. PubMed ID: 2054699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine-receptor antagonists and hepatic encephalopathy: where do we stand?
    Mullen KD; Basile AS
    Gastroenterology; 1993 Sep; 105(3):937-40. PubMed ID: 8395446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.